language
Neo-Pred® – Neoantigen Prediction Platform
Neo-Pred® is an intelligent neoantigen prediction platform developed by Sinorda Pharma. It can read various high-throughput sequencing data, enabling rapid and accurate prediction of tumor neoantigens.
Platform features:
● Autonomous IP prediction algorithm: Offers high prediction accuracy, surpassing the current accuracy rate of TESLA (International New Antigen Screening Alliance).
● Broad prediction scope: In addition to predicting conventional point mutations, it also includes information on insertions, deletions, fusions, splicing events, and more.
● Wide range of applications: including DNA/RNA vaccines, DC vaccines, and neoantigen T-cell therapy development
Consultation Hotline
